AccScience Publishing / JCTR / Online First / DOI: 10.36922/JCTR026420119
Cite this article
9
Views
Related Info Links
More by Authors Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
EDITORIAL

Flu vaccines 2026–2027: An early season leaves no time to wait

Jacek Z. Kubiak1,2*
Show Less
1 Institute of Genetics and Development of Rennes, UMR 6290 CNRS/University of Rennes, Faculty of Medicine, Rennes , France
2 Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine-National Research Institute (WIM-PIB), Szaserow 128, Warszawa , Poland
Received: 14 October 2026 | Published online: 22 October 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Conflict of interest
Jacek Z. Kubiak serves as one of the Editors-in-Chief of this journal, but was not in any way involved in the editorial and peer-review process conducted for this paper, directly or indirectly. The author also declares that he has no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
References
  1. Lenharo M. Flu season could kick off ‘incredibly’ early – what scientists are watching. Nature. 2026;658(8136):585-586. doi: 10.1038/d41586-026-03150-8
  2. Centers for Disease Control and Prevention. Weekly US Influenza Surveillance Report: Key Updates for Week 38, ending September 26, 2026. FluView. 2026. Accessed October 10, 2026. https://www.cdc.gov/fluview/surveillance/2026-week-38.html
  3. Kikawa C, Butler A, Huddleston J, et al. Near real-time data on the human neutralizing antibody landscape to influenza virus in summer of 2026 shows antigenic advance of H3N2 subclade K region D mutants and H1N1 D.3.1.1 Sa mutants. bioRxiv. 2026. doi: 10.64898/2026.09.15.751855
  4. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2026-2027 northern hemisphere influenza season. 2026. Accessed October 10, 2026. https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2026-2027-northern-hemisphere-influenza-season
  5. European Medicines Agency. EU recommendations for 2026/2027 seasonal flu vaccine composition. 2026. Accessed October 10, 2026. https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition
  6. Centers for Disease Control and Prevention. 2026-2027 Flu Season. 2026. Accessed October 10, 2026. https://www.cdc.gov/flu/season/2026-2027.html
  7. Shenai D. Will the mRNA flu shot work better than a regular seasonal one? What the science says. Nature. 2026;656(8129):802-803. doi: 10.1038/d41586-026-02502-8
  8. Centers for Disease Control and Prevention. Interim Clinical Considerations for the Use of Seasonal Influenza Vaccines in the United States. 2026. Accessed October 10, 2026. https://www.cdc.gov/flu/hcp/vax-summary/seasonal-influenza-vaccines.html
  9. Littrell A. AAFP issues fall vaccine recommendations amid competing guidance. Medical Economics. 2026. Accessed October 10, 2026. https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance
  10. Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2026-2027: Policy Statement. Pediatrics. 2026. doi: 10.1542/peds.2026-078778
Share
Back to top
Journal of Clinical and Translational Research, Electronic ISSN: 2424-810X Print ISSN: 2382-6533, Published by AccScience Publishing